Stockscreener 앱 받기
42.51
0.79%
-0.34
시간 외 거래:
41.50
-1.01
-2.38%
전일 마감가:
$42.85
열려 있는:
$41.79
하루 거래량:
1.36M
Relative Volume:
0.92
시가총액:
$4.00B
수익:
$4.72M
순이익/손실:
$-277.91M
주가수익비율:
-11.40
EPS:
-3.73
순현금흐름:
$-203.56M
1주 성능:
+1.07%
1개월 성능:
+4.04%
6개월 성능:
+25.92%
1년 성능:
-25.18%
1일 변동 폭
$41.50
$42.78
1주일 범위
$41.12
$44.70
52주 변동 폭
$24.10
$62.53
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
명칭
Crinetics Pharmaceuticals Inc
전화
858-450-6464
주소
6055 LUSK BLVD., SAN DIEGO, CA
CRNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRNX
Crinetics Pharmaceuticals Inc
|
42.51 | 4.04B | 4.72M | -277.91M | -203.56M | -3.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 개시 | Goldman | Neutral |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-11 | 개시 | TD Cowen | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Peer Perform |
| 2025-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-03-06 | 개시 | Citigroup | Buy |
| 2024-01-16 | 개시 | Morgan Stanley | Overweight |
| 2023-12-21 | 개시 | Jefferies | Hold |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-08-31 | 개시 | Oppenheimer | Outperform |
| 2023-04-24 | 개시 | Piper Sandler | Overweight |
| 2023-03-30 | 개시 | Robert W. Baird | Outperform |
| 2021-11-30 | 개시 | JMP Securities | Mkt Outperform |
| 2021-11-23 | 개시 | Evercore ISI | Outperform |
| 2021-06-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-23 | 개시 | ROTH Capital | Buy |
| 2019-02-14 | 개시 | H.C. Wainwright | Buy |
| 2018-08-13 | 개시 | JP Morgan | Neutral |
| 2018-08-13 | 개시 | Leerink Partners | Outperform |
| 2018-08-13 | 개시 | Piper Jaffray | Overweight |
모두보기
Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스
Quantitative breakdown of Crinetics Pharmaceuticals Inc. recent move2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Will Crinetics Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
What institutional flow reveals about Crinetics Pharmaceuticals Inc.July 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Crinetics Pharmaceuticals Inc. stock trend outlook and recovery pathPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Analyzing recovery setups for Crinetics Pharmaceuticals Inc. investorsPortfolio Risk Report & AI Driven Price Predictions - newser.com
Why Crinetics Pharmaceuticals Inc. (6Z4) stock attracts HNW investorsJobs Report & Verified Chart Pattern Signals - newser.com
Will Crinetics Pharmaceuticals Inc. stock deliver better than expected guidance2025 Pullback Review & Free Verified High Yield Trade Plans - newser.com
Why Crinetics Pharmaceuticals Inc. is moving todayGDP Growth & Fast Gain Stock Trading Tips - newser.com
Identifying reversal signals in Crinetics Pharmaceuticals Inc.2025 Performance Recap & Risk Controlled Daily Plans - newser.com
How interest rate cuts could boost Crinetics Pharmaceuticals Inc. stockJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Top chart patterns to watch in Crinetics Pharmaceuticals Inc.2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Backtesting results for Crinetics Pharmaceuticals Inc. trading strategiesPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
Can Crinetics Pharmaceuticals Inc. rally from current levelsTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com
Chart based analysis of Crinetics Pharmaceuticals Inc. trendsJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
Is Crinetics Pharmaceuticals Inc. stock entering bullish territoryGDP Growth & Verified High Yield Trade Plans - newser.com
Sector ETF performance correlation with Crinetics Pharmaceuticals Inc.2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
Using data tools to time your Crinetics Pharmaceuticals Inc. exit2025 Analyst Calls & Smart Allocation Stock Reports - newser.com
Can Crinetics Pharmaceuticals Inc. (6Z4) stock deliver double digit returnsMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com
Pier Capital LLC Boosts Stock Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals, Inc. $CRNX Shares Acquired by State of New Jersey Common Pension Fund D - MarketBeat
Will Crinetics Pharmaceuticals Inc. (6Z4) stock rise with strong economyJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Is Crinetics Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Automated trading signals detected on Crinetics Pharmaceuticals Inc.July 2025 Trends & Stepwise Trade Signal Guides - newser.com
Crinetics (CRNX) Is Up 6.1% After New Paltusotine Data Presented at Neuroendocrine Tumor Meeting - Sahm
Crinetics Pharmaceuticals Inc 6Z4 Stock Analysis and ForecastSector Performance Review & Free Record-Breaking Gains - earlytimes.in
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Jennison Associates LLC Has $57.15 Million Holdings in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Crinetics Pharmaceuticals Inc (CRNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):